Triggering of RNA Interference with RNA-RNA, RNA-DNA, and DNA-RNA Nanoparticles Shows Promise for Therapeutic Use

Strategic Insights -

Researchers at the National Cancer Institute have developed RNA and RNA/DNA-based nanoparticles designed to conditionally activate RNA interference in human cells. These nanoparticles demonstrate precise control over their formulation, stability in blood serum, and activation of multiple functionalities. The study, published in ACS Nano, found that DNA nanoparticles showed significantly lower responses in interferon and pro-inflammatory cytokine activation assays compared to RNA counterparts, indicating potential for therapeutic use.

Key Takeaways:

  • Researchers at the National Cancer Institute developed RNA and RNA/DNA-based nanoparticles to conditionally activate RNA interference in human cells.
  • The nanoparticles allow for precise control over their formulation, stability in blood serum, and activation of multiple functionalities.
  • DNA nanoparticles showed significantly lower responses in interferon and pro-inflammatory cytokine activation assays compared to RNA counterparts.
  • This suggests greater potential for therapeutic use of DNA nanoparticles.
  • The study highlights the importance of synchronized activation of multiple functionalities in cellular delivery systems.
  • The nanoparticles were designed to conditionally activate RNA interference, a critical mechanism for regulating gene expression.

Statistics:

  • 251-259 is the page range of the study published in ACS Nano.
  • The research was conducted by K.A. Afonin and his team at the National Cancer Institute's Gene Regulat & Chromosome Biol Lab.
  • The study involved the development of RNA-RNA, RNA-DNA, and DNA-RNA nanoparticles.
  • Interferon and pro-inflammatory cytokine activation assays were used to evaluate the responses of the nanoparticles.
  • The study found significantly lower responses for DNA nanoparticles compared to RNA counterparts.

Sources:

  • "Triggering of RNA Interference with RNA-RNA, RNA-DNA, and DNA-RNA Nanoparticles" published in ACS Nano, 2015;9(1):251-259.
  • American Chemical Society - www.acs.org
  • ACS Nano - www.pubs.acs.org/journal/ancac3
  • National Cancer Institute - www.cancer.gov
  • Gene Regulat & Chromosome Biol Lab - National Institutes of Health - Frederick, MD 21702, United States
  • K.A. Afonin - National Cancer Institute - Gene Regulat & Chromosome Biol Lab - Center Canc Res - National Institutes of Health - Frederick, MD 21702, United States.